Published by IMARC Services Private Limited
Posted on October 8, 2021
4 min readLast updated: January 30, 2026
The US transfection technologies market is set for moderate growth from 2021-2026, driven by rising demand for cell-based products and increased R&D activities.
The United States Transfection Technologies Market is expected to exhibit moderate growth during 2021-2026. The report provides a detailed analysis of the market by Product Type, Application, Transfection Method, Technology, End User, Region.
Report Metric
Historical: 2015-2020
Base Year: 2020
Forecast Year: 2021-2026
Download free sample of the report: https://www.imarcgroup.com/united-states-transfection-technologies-market/requestsample
Industry Definition and Application:
Transfection technology refers to the method of artificially introducing various nucleic acids, such as oligonucleotides, Deoxyribonucleic Acid (DNA), and Ribonucleic Acid (RNA), into the eukaryotic cells. It can be done using biological, physical, and chemical methods, which aid in modifying specific properties of the cell. Transfection includes electroporation, cationic lipid transfection, in-vivo transfection, etc. At present, it is extensively used for numerous genomic studies, including gene expression, RNA interference, screening, etc.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Read Our Latest Report Blog @ http://imarcgroup.weebly.com/
Market Trends and Drivers:
The elevating number of cases of infectious diseases that require antibiotics is driving the transfection technologies market in the United States. Additionally, the rising utilization of cell-based products is also augmenting the demand for transfection methods to treat various chronic diseases, such as tuberculosis, cardiovascular diseases, cancer, etc. Moreover, several reagent-based transfection technologies, including laserfection, biolistic technology, and microinjection, are gaining traction based on their accuracy and cost-effectiveness. Besides this, numerous manufacturers are focusing on extensive R&D activities for advanced cytological studies, cancer therapeutics, and precision medicine, which are also fueling the market growth in the country. Apart from this, increasing investments by both private and government bodies to develop large-scale transfection facilities are further anticipated to bolster the United States market over the forecasted period.
Browse full report with TOC: https://www.imarcgroup.com/united-states-transfection-technologies-market
United States Transfection Technologies MarketSegmentation:
The report has segmented the market on the basis of Product Type, Application, Transfection Method, Technology, End User, Region.
Breakup by Product Type:
· Reagent
· Instrument
· Others
Breakup by Application:
· Therapeutic Delivery
· Bio-Medical Research
· Protein Production
· Others
Breakup by Transfection Method:
· Lipofection
· Eletroporation
· Nucleofection
· Cotransfection
· Cationic Lipid Transfection
· In-Vivo Transfection
· Others
Breakup by Technology:
· Physical Transfection
· Biochemical Based Transfection
· Viral-Vector Based Transfection
Breakup by End User:
· Research Centers and Academic Institutes
· Hospitals and Clinics
· Pharmaceutical and Biotechnology Companies
· Others
Breakup by Region:
· Northeast
· Midwest
· South
· West
Related Report by IMARC Group:
United States Insulin Pumps Market Report: https://www.imarcgroup.com/united-states-insulin-pumps-market
Recombinant DNA Technology Market Report: https://www.imarcgroup.com/recombinant-dna-technology-market
Protein Purification and Isolation Market Report: https://www.imarcgroup.com/protein-purification-isolation-market
Drug Abuse Testing Market Report: https://www.imarcgroup.com/drug-abuse-testing-market
Veterinary Infectious Disease Diagnostics Market Report: https://www.imarcgroup.com/veterinary-infectious-disease-diagnostics-market
Premenstrual Syndrome Treatment Market Report: https://www.imarcgroup.com/premenstrual-syndrome-treatment-market
India Generic Injectables Market Report: https://www.imarcgroup.com/india-generic-injectables-market
India Organ Preservation Market Report: https://www.imarcgroup.com/india-organ-preservation-market
Europe CBD Oil Market Report: https://www.imarcgroup.com/europe-cbd-oil-market
Latin America Generic Injectables Market Report: https://www.imarcgroup.com/latin-america-generic-injectables-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact Us
Olivia Anderson
Marketing Manager
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
LinkedIn: https://in.linkedin.com/company/imarc-group
The article discusses the growth and trends in the US transfection technologies market from 2021 to 2026.
What factors are driving the US transfection technologies market growth?
How are reagent-based transfection technologies impacting the market?
Explore more articles in the Research Reports category
